Inhibition of peptidoleukotriene responses does not moderate ischemic damage or neutrophil infiltration in myocardium following coronary artery occlusion with reperfusion.
Smith
E F
EF
Smith Kline and French Labs., Dept. of Pharmacology, King of Prussia, PA 19406.
Egan
J W
JW
Hillegass
L M
LM
Slivjak
M J
MJ
Griswold
D E
DE
D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D003327:Coronary Disease / Q000209:etiology* / Q000473:pathology; D003998:Dicarboxylic Acids / Q000494:pharmacology; D020024:Leukotriene Antagonists; D015289:Leukotrienes / Q000502:physiology*; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000209:etiology; D009504:Neutrophils / Q000187:drug effects / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains
D003998:Dicarboxylic Acids; D020024:Leukotriene Antagonists; D015289:Leukotrienes; C052393:pobilukast